Abstract
DNA was alkylated in neutral solution at 37 degrees C with 1,2:5,6-dianhydrogalactitol and hydrolysed to yield two principal products, identified as 7-galactitylguanine and 1,6-dideoxy-1,6-di(guanin-7-yl)galactitol. The reaction products were separated by chromatography on Sephadex G-10 and Dowex 50 (H+ form). The two compounds were also obtained by reaction between dianhydrogalactitol and guanosine in acetic acid. The products were characterized from their u.v.-spectral data by comparison with those of the 7-alkylguanines and were also identified by mass spectrometry.
Full text
PDFSelected References
These references are in PubMed. This may not be the complete list of references from this article.
- Ahmann D. L., O'Connell M. J., Bisel H. F., Edmonson J. H., Hahn R. G., Frytak S. Phase II study of dianhydrogalactitol and ICRF-159 in patients with advanced breast cancer previously exposed to cytotoxic chemotherapy. Cancer Treat Rep. 1977 Jan-Feb;61(1):81–82. [PubMed] [Google Scholar]
- Brookes P., Lawley P. D. The reaction of mono- and di-functional alkylating agents with nucleic acids. Biochem J. 1961 Sep;80(3):496–503. doi: 10.1042/bj0800496. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Eagan R. T., Ingle J. N., Frytak S., Rubin J., Kvols L. K., Carr D. T., Coles D. T., O'Fallon J. R. Platinum-based polychemotherapy versus dianhydrogalactitol in advanced non-small cell lung cancer. Cancer Treat Rep. 1977 Oct;61(7):1339–1345. [PubMed] [Google Scholar]
- Espana P., Wiernik P. H., Walker M. D. Phase II study of dianhydrogalactitol in malignant glioma. Cancer Treat Rep. 1978 Aug;62(8):1199–1200. [PubMed] [Google Scholar]
- Hoogstraten B., O'Bryan R., Jones S. 1,2:5,6-Dianhydrogalactitol in advanced breast cancer. Cancer Treat Rep. 1978 May;62(5):841–842. [PubMed] [Google Scholar]
- Institoris E., Fox B. W. The interaction of dianhydrogalactitol with DNA in cultured Yoshida sarcoma cells. Chem Biol Interact. 1978 Jul;22(1):99–107. doi: 10.1016/0009-2797(78)90153-9. [DOI] [PubMed] [Google Scholar]
- LAWLEY P. D., BROOKES P. FURTHER STUDIES ON THE ALKYLATION OF NUCLEIC ACIDS AND THEIR CONSTITUENT NUCLEOTIDES. Biochem J. 1963 Oct;89:127–138. doi: 10.1042/bj0890127. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lawley P. D., Jarman M. Alkylation by propylene oxide of deoxyribonucleic acid, adenine, guanosine and deoxyguanylic acid. Biochem J. 1972 Feb;126(4):893–900. doi: 10.1042/bj1260893. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lawley P. D., Orr D. J., Jarman M. Isolation and identification of products from alkylation of nucleic acids: ethyl- and isopropyl-purines. Biochem J. 1975 Jan;145(1):73–84. doi: 10.1042/bj1450073. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lawley P. D., Thatcher C. J. Methylation of deoxyribonucleic acid in cultured mammalian cells by N-methyl-N'-nitro-N-nitrosoguanidine. The influence of cellular thiol concentrations on the extent of methylation and the 6-oxygen atom of guanine as a site of methylation. Biochem J. 1970 Feb;116(4):693–707. doi: 10.1042/bj1160693. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Miller V., Pacáková V., Smolková E. Gas-liquid chromatographic analysis of trimethylsilyl derivatives of pyrimidine and purine bases and nucleosides. J Chromatogr. 1976 Apr 28;119:355–367. doi: 10.1016/s0021-9673(00)86799-0. [DOI] [PubMed] [Google Scholar]
- Németh L., Institóris L., Somfai S., Gál F., Pályi I., Sugár J., Csuka O., Szentirmay Z., Kellner B. Pharmacologic and antitumor effects of 1,2:5,6-dianhydrogalactitol (NSC-132313). Cancer Chemother Rep. 1972 Oct;56(5):593–602. [PubMed] [Google Scholar]
- Pályi I. Survival and phase sensitivity of HeLa cells treated with dianhydrogalactitol (NSC-132313). Cancer Chemother Rep. 1975 May-Jun;59(3):493–499. [PubMed] [Google Scholar]